AAAAAA
Results: 1-25/50
Authors:
Menard, S
Camerini, T
Mariani, L
Tomasic, G
Pilotti, S
Costa, A
De Palo, G
Veronesi, U
Citation: S. Menard et al., Re: Randomized trial of fenretinide to prevent second breast malignancy inwomen with early breast cancer, J NAT CANC, 93(3), 2001, pp. 240-241
Authors:
Agus, V
Tamborini, E
Mezzelani, A
Pierotti, MA
Pilotti, S
Citation: V. Agus et al., Re: A novel fusion gene, SYT-SSX4, in synovial sarcoma, J NAT CANC, 93(17), 2001, pp. 1347-1348
Authors:
Perotti, D
Testi, MA
Mondini, P
Pilotti, S
Green, ED
Pession, A
Sozzi, G
Pierotti, MA
Fossati-Bellani, F
Radice, P
Citation: D. Perotti et al., Refinement within single yeast artificial chromosome clones of a minimal region commonly deleted on the short arm of chromosome 7 in Wilms tumours, GENE CHROM, 31(1), 2001, pp. 42-47
Authors:
Menard, S
Valagussa, P
Pilotti, S
Gianni, L
Biganzoli, E
Boracchi, P
Tomasic, G
Casalini, P
Marubini, E
Colnaghi, MI
Cascinelli, N
Bonadonna, G
Citation: S. Menard et al., Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables, J CL ONCOL, 19(2), 2001, pp. 329-335
Authors:
Collini, P
Sampietro, G
Bertulli, R
Casali, PG
Luksch, R
Mezzelani, A
Sozzi, G
Pilotti, S
Citation: P. Collini et al., Cytokeratin immunoreactivity in 41 cases of ES/PNET confirmed by moleculardiagnostic studies, AM J SURG P, 25(2), 2001, pp. 273-274
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors
Authors:
Birindelli, S
Perrone, F
Oggionni, M
Lavarino, C
Pasini, B
Vergani, B
Ranzani, GN
Pierotti, MA
Pilotti, S
Citation: S. Birindelli et al., Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors, LAB INV, 81(6), 2001, pp. 833-844
Authors:
Tamborini, E
Della Torre, G
Lavarino, C
Azzarelli, A
Carpinelli, P
Pierotti, MA
Pilotti, S
Citation: E. Tamborini et al., Analysts of the molecular species generated by MDM2 gene amplification in liposarcomas, INT J CANC, 92(6), 2001, pp. 790-796
Authors:
Azzarelli, A
Gronchi, A
Bertulli, R
Tess, JDT
Baratti, D
Pennacchioli, E
Dileo, P
Rasponi, A
Ferrari, A
Pilotti, S
Casali, PG
Citation: A. Azzarelli et al., Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis, CANCER, 92(5), 2001, pp. 1259-1264
Authors:
Tamborini, E
Papini, D
Mezzelani, A
Riva, C
Azzarelli, A
Sozzi, G
Pierotti, MA
Pilotti, S
Citation: E. Tamborini et al., c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases, BR J CANC, 85(3), 2001, pp. 405-411
Authors:
Tamborini, E
Agus, V
Mezzelani, A
Riva, C
Sozzi, G
Azzarelli, A
Pierotti, MA
Pilotti, S
Citation: E. Tamborini et al., Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma, BR J CANC, 84(8), 2001, pp. 1087-1094
Authors:
Bijker, N
Peterse, JL
Duchateau, L
Robanus-Maandag, EC
Bosch, CAJ
Duval, C
Pilotti, S
van de Vijver, MJ
Citation: N. Bijker et al., Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinomain situ, BR J CANC, 84(4), 2001, pp. 539-544
Authors:
Alasio, LM
Alphandery, C
Grassi, P
Ruggeri, M
De Palo, G
Pilotti, S
Citation: Lm. Alasio et al., Performance of the AutoPap Primary Screening System in the detection of high-risk cases in cervicovaginal smears, ACT CYTOL, 45(5), 2001, pp. 704-708
Authors:
Pilotti, S
Mezzelani, A
Vergani, B
Minoletti, F
Cristofori, E
Sozzi, G
Pierotti, MA
Citation: S. Pilotti et al., Morphologic-cytogenetic analysis of dedifferentiated liposarcomas with an extensive misleading leiomyosarcomatous component, APPL IMMUNO, 8(3), 2000, pp. 216-221
Authors:
Sampietro, G
Tomasic, G
Collini, P
Biganzoli, E
Boracchi, P
Bidoli, P
Pilotti, S
Citation: G. Sampietro et al., Gene product immunophenotyping of neuroendocrine lung tumors - No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis, APPL IMMUNO, 8(1), 2000, pp. 49-56
Authors:
Mezzelani, A
Dagrada, GP
Sozzi, G
Pierotti, MA
Pilotti, S
Citation: A. Mezzelani et al., SYT-SSX fusion transcripts and epithelial differentiation in synovial sarcoma, DIAGN MOL P, 9(4), 2000, pp. 234-234
Authors:
Della Torre, G
Pasquini, G
Pilotti, S
Alasio, L
Civelli, E
Cozzi, G
Milella, M
Salvetti, M
Pierotti, MA
Severini, A
Citation: G. Della Torre et al., TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas, DIAGN MOL P, 9(1), 2000, pp. 41-46
Authors:
De Palo, G
Stefanon, B
Alasio, L
Pilotti, S
Citation: G. De Palo et al., Exact Touch: a new device for cervical cytology. Comparison with Ayre spatula plus Cytobrush, CYTOPATHOLO, 11(5), 2000, pp. 322-325
Authors:
Mastrangelo, T
Modena, P
Tornielli, S
Bullrich, F
Testi, MA
Mezzelani, A
Radice, P
Azzarelli, A
Pilotti, S
Croce, CM
Pierotti, MA
Sozzi, G
Citation: T. Mastrangelo et al., A novel zinc finger gene is fused to EWS in small round cell tumor, ONCOGENE, 19(33), 2000, pp. 3799-3804
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma
Authors:
Lavarino, C
Pilotti, S
Oggionni, M
Gatti, L
Perego, P
Bresciani, G
Pierotti, MA
Scambia, G
Ferrandina, G
Fagotti, A
Mangioni, C
Lucchini, V
Vecchione, F
Bolis, G
Scarfone, G
Zunino, F
Citation: C. Lavarino et al., p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma, J CL ONCOL, 18(23), 2000, pp. 3936-3945
Authors:
Botti, C
Seregni, E
Menard, S
Collini, P
Tagliabue, E
Campiglio, M
Vergani, B
Ghirelli, C
Aiello, P
Pilotti, S
Bombardieri, E
Citation: C. Botti et al., Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer, INT J B MAR, 15(4), 2000, pp. 312-320
Authors:
Mezzelani, A
Sozzi, G
Nessling, M
Riva, C
Della Torre, G
Testi, MA
Azzarelli, A
Pierotti, MA
Lichter, P
Pilotti, S
Citation: A. Mezzelani et al., Low grade fibromyxoid sarcoma: a further low-grade soft tissue malignancy characterized by a ring chromosome, CANC GENET, 122(2), 2000, pp. 144-148
Authors:
Crippa, F
Leutner, M
Belli, F
Gallino, F
Greco, M
Pilotti, S
Cascinelli, N
Bombardieri, E
Citation: F. Crippa et al., Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma, J NUCL MED, 41(9), 2000, pp. 1491-1494
Authors:
Di Palma, S
Corletto, V
Lavarino, C
Birindelli, S
Pilotti, S
Citation: S. Di Palma et al., Dedifferentiation in salivary gland carcinomas, AM J SURG P, 24(10), 2000, pp. 1439-1440
Authors:
Pezzella, F
Manzotti, M
Di Bacco, A
Viale, G
Nicholson, AG
Price, R
Ratcliffe, C
Pastorino, U
Gatter, KC
Harris, AL
Altman, DG
Pilotti, S
Veronesi, U
Citation: F. Pezzella et al., Evidence for novel non-angiogenic pathway in breast-cancer metastasis, LANCET, 355(9217), 2000, pp. 1787-1788
Authors:
Mancuso, T
Mezzelani, A
Riva, C
Fabbri, A
Dal Bo, L
Sampietro, G
Perego, P
Casali, P
Zunino, F
Sozzi, G
Pierotti, MA
Pilotti, S
Citation: T. Mancuso et al., Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma, LAB INV, 80(6), 2000, pp. 805-813